Ajay Mansukhlal Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajay Mansukhlal Patel, a promoter of Tatva Chintan Pharma Chem, has submitted an annual declaration to NSE and BSE as required under Regulation 31(4) of the SEBI Takeover Regulations. In the filing, the promoter confirms that he and persons acting in concert have not created any encumbrance (such as a pledge or lien) on the company's shares, directly or indirectly, during the financial year ended 31 March 2025. The declaration covers the full promoter group including Ajay Mansukhlal Patel (HUF) and Priti Ajay Patel. This is a routine annual compliance disclosure and not a change in shareholding.
This is a neutral, routine compliance filing. It reassures investors that promoters have not pledged or otherwise encumbered their shares during the year, which is mildly positive as pledging is often viewed as a risk signal.